Constellation Pharmaceuticals Inc (CNST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,475 | 88,540 | N/A | N/A | N/A |
| TOTAL | $132,012 | $90,605 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 825 | 885 | N/A | N/A | N/A |
| Other Non-Current Assets | 425 | 3,132 | 0 | 0 | 0 |
| TOTAL | $1,250 | $4,017 | $N/A | $N/A | $N/A |
| Total Assets | $133,262 | $94,622 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 605 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,309 | 2,679 | 0 | 0 | 0 |
| Accrued Expenses | 6,212 | 6,129 | N/A | N/A | N/A |
| TOTAL | $10,521 | $9,413 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 178 | 590 | 0 | 0 | 0 |
| TOTAL | $178 | $590 | $N/A | $N/A | $N/A |
| Total Liabilities | $10,699 | $10,003 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,785 | 25,719 | N/A | N/A | N/A |
| Common Shares | 3 | 0 | N/A | N/A | N/A |
| Retained earnings | -213,893 | -197,955 | N/A | N/A | N/A |
| Other shareholders' equity | 0 | 272,834 | 0 | 0 | 0 |
| TOTAL | $122,563 | $84,619 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $133,262 | $94,622 | $0 | $0 | $0 |